As seen on shelf at Walgreens, having a major pharma player like Bayer HealthCare field what essentially is a hangover-relief product adds credibility, not to mention a little more shelf presence, to similar products like Living Essentials’ Chaser Plus.
Study finds fiber may be beneficial to children’s diet
GAINESVILLE, Fla. A University of Florida study released earlier this month touted the benefits of fiber in children as a possible preventative measure for obesity and diabetes.
“[Fiber] actually has lots of health … in managing childhood obesity,” said University of Florida researcher Rick Davis during University of Florida News webcast. “High fiber foods tend to be more filling; children eat less,” he said.
Soluble fibers are especially beneficial in the prevention of obesity and diabetes. “In those who have obesity, diabetes, pre-diabetes or a history of diabetes in their family, or maybe early elevations of cholesterol that they’re not ready for medications, high fiber diets can be part of [the regimen] as far as maybe preventing or delaying the disease,” Davis added.
XenaCare receives ‘Best New Product’ award at conference
DELRAY BEACH, Fla. XenaCare Holdings on Monday announced that its stage 2 pain reliever, Cobroxin, has won the award for “Best New Product,” sponsored by Drug Store News, at the recent ECRM Health held in Miami.
“It is an honor to have Cobroxin chosen as the best new product at ECRM,” stated Frank Rizzo, president of XenaCare. “This award … supports our belief that Cobroxin will soon become the preferred alternative to current opiate and acetaminophen-based analgesics,” he concluded.
Retailer attendees nominate and vote on “Best New Product” at the show.
Cobroxin is the first opiate and acetaminophen-free pain reliever available as an over-the-counter formulation clinically proven to treat moderate to severe (Stage 2) pain. Recently, XenaCare Holdings was awarded the exclusive license for marketing and distributing Cobroxin within the United States.
As part of Drug Store News’ sponsorship of the award, XenaCare Holdings will receive a full-page advertisement in an upcoming issue of Drug Store News.